Azamulin is a semi-synthetic pleuromutilin derivative that failed Stage 1 clinical trials due to poor bioavailability.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
pleuromutilin antibioticARO:3000670
ARO:3000670| Molecular formula | C24H38N4O4S |
|---|---|
| Charge | 0 |
| Average mass | 478.6 Da |
| Monoisotopic mass | 478.26137688 Da |
| Source | PubChem · retrieved 2026-08-29 |
| InChIKey | FMHQJXGMLMSMLC-WBUYAQKGSA-N |
CC[C@@]1(C[C@H]([C@@]2([C@@H](CC[C@@]3([C@H]2C(=O)CC3)[C@H]([C@@H]1O)C)C)C)OC(=O)CSC4=NNC(=N4)N)C
InChI=1S/C24H38N4O4S/c1-6-22(4)11-16(32-17(30)12-33-21-26-20(25)27-28-21)23(5)13(2)7-9-24(14(3)19(22)31)10-8-15(29)18(23)24/h13-14,16,18-19,31H,6-12H2,1-5H3,(H3,25,26,27,28)/t13-,14+,16-,18+,19+,22-,23+,24+/m1/s1
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3001316 |
azamulin | antibioticmech:aro-148ae939a4 |
2026-08-30 |
Seeded from data/raw/ inventories (ARO)
Re-seeded from updated data/raw/ inventories
Re-seeded from updated data/raw/ inventories